Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest	Total
Balances (in shares) at Jun. 30, 2021	155,822,000
Balances at Jun. 30, 2021	$ 1,558	$ 533,239	$ 1,085,465	$ (57,291)	$ 8,263	$ 1,571,234
Net earnings			272,051		(8,952)	263,099
Other comprehensive income (loss)				(17,909)	(70)	$ (17,979)
Share repurchases (in shares)	(1,577,000)					(1,576,952)
Share repurchases	$ (16)		(160,934)			$ (160,950)
Common stock issued for exercise of options (in shares)	2,282,000					2,450,000
Common stock issued for exercise of options	$ 23	74,354	(13,482)			$ 60,895
Common stock issued for restricted stock awards (in shares)	89,000
Common stock issued for restricted stock awards	$ 1	(1)	(9,978)			(9,978)
Cash dividends			(50,185)			(50,185)
Stock-based compensation expense		41,208				41,208
Common stock issued to employee stock purchase plan (in shares)	28,000
Common stock issued to employee stock purchase plan	$ 0	2,694				2,694
Employee stock purchase plan expense		973				973
Balances (in shares) at Jun. 30, 2022	156,644,000
Balances at Jun. 30, 2022	$ 1,566	652,467	1,122,937	(75,200)	(759)	1,701,011
Reclassification of cumulative translation adjustment for Eminence to non-operating income				152	(33)	119
Elimination of noncontrolling equity interest from sale of Eminence					613	613
Net earnings			285,263		$ 179	285,442
Other comprehensive income (loss) before reclassification				8,984		8,984
Other comprehensive income (loss)						$ 9,103
Share repurchases (in shares)	(222,000)					(222,000)
Share repurchases	$ (2)		(19,560)			$ (19,562)
Common stock issued for exercise of options (in shares)	1,083,000					1,578,000
Common stock issued for exercise of options	$ 10	24,942	(22,163)			$ 2,789
Common stock issued for restricted stock awards (in shares)	63,000
Common stock issued for restricted stock awards	$ 1	(1)	(6,731)			(6,731)
Cash dividends			(50,285)			(50,285)
Stock-based compensation expense		38,315				38,315
Common stock issued to employee stock purchase plan (in shares)	74,000
Common stock issued to employee stock purchase plan	$ 1	4,905				4,906
Employee stock purchase plan expense		915				$ 915
Balances (in shares) at Jun. 30, 2023	157,642,000					157,641,914
Balances at Jun. 30, 2023	$ 1,576	721,543	1,309,461	(66,064)		$ 1,966,516
Net earnings			168,105			168,105
Other comprehensive income (loss)				(12,252)		$ (12,252)
Share repurchases (in shares)	(1,397,000)					(1,397,471)
Share repurchases	$ (14)		(80,028)			$ (80,042)
Common stock issued for exercise of options (in shares)	1,811,000					2,240,000
Common stock issued for exercise of options	$ 18	56,409	(16,534)			$ 39,893
Common stock issued for restricted stock awards (in shares)	91,000
Common stock issued for restricted stock awards	$ 1	(1)	(5,338)			(5,338)
Cash dividends			(50,419)			(50,419)
Stock-based compensation expense		37,136				37,136
Common stock issued to employee stock purchase plan (in shares)	69,000
Common stock issued to employee stock purchase plan	$ 1	4,344				4,345
Employee stock purchase plan expense		906				$ 906
Balances (in shares) at Jun. 30, 2024	158,216,000					158,216,258
Balances at Jun. 30, 2024	$ 1,582	$ 820,337	$ 1,325,247	$ (78,316)		$ 2,068,850